- 801. SecB protein
- [ ] (UMLS (CSP) C0074244) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 851. Secondary Myelofibrosis
- (UMLS (NCI) C0242006) =Disease or Syndrome
|
- 802. Secnidazole
- (UMLS (NCI) C0074246) =Organic Chemical; Pharmacologic Substance ;
| - 852. Secondary Oocyte
- [A female germ cell in which the first meiotic division is completed. The second meiotic division usually stops short of completion unless fertilization occurs. ( NCI )] (UMLS (NCI) C0227882) =Cell
|
- 803. SECOBARBITAL
- [A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity. ( MSH )] (UMLS (NCI) C0036516) =Organic Chemical; Pharmacologic Substance =barbiturate;
[CN301] BARBITURIC ACID DERIVATIVE, SEDATIVES/HYPNOTICS =SECOBARBITAL SODIUM;
| - 853. secondary performer
- [A person assisting in an act through his substantial presence and involvement This includes: assistants, technicians, associates, or whatever the job titles may be. ( HL7V3.0 )] (UMLS (HL7) C1552015) =Idea or Concept =performer;
|
- 804. second
- (UMLS (HL7) C1561503) =Idea or Concept =Precision;
| - 854. Secondary pigmentary degeneration of retina
- [ ] (UMLS (ICD9CM) C0154858) =Disease or Syndrome
|
- 805. Second
- [Coming next after the first in position in space or time or degree or magnitude. ( NCI )] (UMLS (NCI) C0205436) =Quantitative Concept
| - 855. SECONDARY PNEUMON PLAGUE
- [ ] (UMLS (ICD9CM) C0152938) =Disease or Syndrome
|
- 806. second (continuous)
- (UMLS (HL7) C1550735) =Temporal Concept =CalendarCycleTwoLetter;
| - 856. Secondary procedures after removal of eyeball
- [ ] (UMLS (ICD9CM) C0196952) =Therapeutic or Preventive Procedure
|
- 807. Second ancillary
- (UMLS (HL7) C1549482) =Idea or Concept =Policy type;
| - 857. Secondary Protein Structure
- [The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to alpha helices, beta strands (which align to form beta sheets) or other types of coils. This is the first folding level of protein conformation. (MeSH) ( NCI )] (UMLS (NCI) C0162807) =Spatial Concept ;
|
- 808. second assistant surgeon
- [In a typical surgery setting the assistant who primarily holds the hooks. ( HL7V3.0 )] (UMLS (HL7) C1550492) =Professional or Occupational Group =ParticipationFunction;
| - 858. Secondary Reason
- (UMLS (HL7) C1549996) =Idea or Concept =Comment type;
|
- 809. second cancer
- [Refers to a new primary cancer that is caused by previous cancer treatment, or a new primary cancer in a person with a history of cancer. ( NCI )] (UMLS (NCI) C0751623) secondary cancer;
Secondary Malignancy;
Secondary Malignancy (After Treatment of Primary Cancer);
Secondary Malignant Neoplasm;
=Neoplastic Process ;
| - 859. SECONDARY RETINAL CYSTS
- [ ] (UMLS (ICD9CM) C0154820) =Disease or Syndrome ;
|
- 810. SECOND CARDIOMYOPATH NOS
- (UMLS (ICD9CM) C0036529) =Disease or Syndrome ;
| - 860. secondary school
- [school intermediate between elementary school and college. ( CSP )] (UMLS (CSP) C0036530) =Manufactured Object; Organization ;
=school;
|
- 811. Second Degree Uterine Prolapse
- (UMLS (NCI) C0269126) =Acquired Abnormality
| - 861. SECONDARY SYPH SKIN
- (UMLS (ICD9CM) C0343677) =Disease or Syndrome
|
- 812. Second intensive care unit
- (UMLS (HL7) C1549472) =Idea or Concept =Room type;
| - 862. SECONDARY SYPHILIS NOS
- (UMLS (ICD9CM) C0149985) =Disease or Syndrome
|
- 813. SECOND IRITIS, NONINFEC
- [ ] (UMLS (ICD9CM) C0154912) =Disease or Syndrome
| - 863. Secondary syphilis of viscera and bone
- (UMLS (ICD9CM) C0343676) =Disease or Syndrome
|
- 814. Second major medical
- (UMLS (HL7) C1549483) =Idea or Concept =Policy type;
| - 864. Secondary syphilitic hepatitis
- [ ] (UMLS (ICD9CM) C0153149) =Disease or Syndrome
|
- 815. SECOND MALIG NEO ADRENAL
- [ ] (UMLS (ICD9CM) C0153691) =Neoplastic Process
| - 865. Secondary syphilitic periostitis
- [ ] (UMLS (ICD9CM) C0153148) =Disease or Syndrome
|
- 816. SECOND MALIG NEO GENITAL
- [ ] (UMLS (ICD9CM) C0153693) =Neoplastic Process
| - 866. Secondary uterine inertia
- (UMLS (ICD9CM) C0405169) =Disease or Syndrome
|
- 817. second messenger
- [diverse family of low molecular weight compounds such as cyclic AMP and calcium ions which transmit the biological signals initiated by receptor-ligand binding at the cell surface to intracellular targets such as gene expression. ( CSP )] (UMLS (CSP) C1508748) =Biologically Active Substance ;
=Signal Transduction;
| - 867. Secretarial Certificate
- (UMLS (HL7) C1549993) =Intellectual Product =Degree/license/certificate;
|
- 818. Second nearest lab
- (UMLS (HL7) C1548584) =Intellectual Product =Location Relationship ID;
| - 868. secretase
- [Endopeptidases that are specific for AMYLOID PROTEIN PRECURSOR. Three secretase subtypes referred to as alpha, beta, and gamma have been identified based upon the region of amyloid protein precursor they cleave. ( MSH )] (UMLS (CSP) C0171484) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 819. Second nearest pharmacy
- (UMLS (HL7) C1548587) =Intellectual Product =Location Relationship ID;
| - 869. Secreted and Transmembrane 1 Gene
- [This gene plays a role in hematopoetic and immune system processes. ( NCI )] (UMLS (NCI) C1335807) SECTM1;
SECTM1 Gene;
=Gene or Genome ;
|
- 820. second of the minute
- (UMLS (HL7) C1549037) =Temporal Concept =Calendar alignment;
CalendarCycleTwoLetter;
CalendarCycleOneLetter;
| - 870. Secreted Frizzled-Related Protein 4 Gene
- [This gene plays a role in signal transduction, apoptosis and cell proliferation. ( NCI )] (UMLS (NCI) C1335814) SFRP4;
SFRP4 Gene;
=Gene or Genome ;
|
- 821. Second Opinion
- (UMLS (HL7) C1548433) =Idea or Concept =Referral disposition;
| - 871. SECRETIN
- [strongly basic polypeptide hormone secreted by the duodenal and jejunal mucosa that activates pancreatic secretion and lowers the blood sugar level; it has a lesser stimulatory effect on bile and intestinal secretion. ( CSP )] (UMLS (NCI) C0036534) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =gastrointestinal hormone;
neuropeptide;
Peptides;
gastric juice inhibitor;
[DX900] DIAGNOSTICS, OTHER;
=SECRETIN 75 UNT;
SECRETIN 100 UNT |
- 822. Second Opinion
- (UMLS (HL7) C1548632) =Idea or Concept =Referral reason;
| - 872. secretion
- [production of a hormone or other substance which will perform a specialized function outside the gland, cell or organ. ( CSP )] (UMLS (CSP) C0036536) =Biologic Function =biological transport;
|
- 823. Second Opinion Documentation Received
- (UMLS (HL7) C1550426) =Finding =HL7 Vocabulary Version 2.5;
| - 873. Secretion(s)
- (UMLS (HL7) C1546773) =Intellectual Product =Specimen Source Codes;
|
- 824. Second Opinion Status
- (UMLS (HL7) C1550425) =Finding =HL7 Vocabulary Version 2.5;
| - 874. Secretion, Nasal
- (UMLS (HL7) C1546724) =Intellectual Product =Specimen Source Codes;
|
- 825. Second Pharyngeal Pouch
- (UMLS (NCI) C0231069) =Embryonic Structure
| - 875. Secretory Granule
- [Usually a protein, it is produced in the granular endoplasmic reticulum and the Golgi complex. Morphologically, it is defined as a membrane-bound particle. ( NCI )] (UMLS (NCI) C0886515) Secretory Vesicle;
=Cell Component |
- 826. Second private room
- (UMLS (HL7) C1549473) =Idea or Concept =Room type;
| - 876. secretory immune system
- [nonencapsulated, interconnected, primarily mucosal aggregates of lymphoid tissue committed to secretory IgA and IgE production in the respiratory, alimentary, and genitourinary tracts. ( CSP )] (UMLS (CSP) C0920314) =Body System =lymphatic tissue;
=Mucosal Immunity;
GALT;
|
- 827. Second semi-private room
- (UMLS (HL7) C1549474) =Idea or Concept =Room type;
| - 877. Secretory Leukocyte Protease Inhibitor (Antileukoproteinase) Gene
- [This gene is involved in the immune response. ( NCI )] (UMLS (NCI) C1366565) SLPI;
SLPI Gene =Gene or Genome |
- 828. SECOND SYPH VISCERA NEC
- [ ] (UMLS (ICD9CM) C0153150) =Disease or Syndrome
| - 878. Secretory Meningioma
- [A WHO grade I meningioma characterized by the presence of pseudo-psammoma bodies: focal epithelial differentiation, in the form of intracellular lumina containing PAS-positive, eosinophilic material. (Adapted from WHO 2000.) - 2004 ( NCI )] (UMLS (NCI) C1384406) =Neoplastic Process
|
- 829. SECOND SYPHILIS RELAPSE
- [ ] (UMLS (ICD9CM) C0153151) =Disease or Syndrome
| - 879. secretory protein
- [any protein which can be secreted by a cell, a property determined by transport mediators, posttranslational modification, and special aminoacid sequences such as hydrophobic membrane anchors. ( CSP )] (UMLS (CSP) C0597427) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=gene product;
=CHG;
mucin;
Extracellular Matrix Protein |
- 830. SECOND THROMBOCYTOPENIA
- [ ] (UMLS (ICD9CM) C0154301) =Disease or Syndrome
| - 880. section
- [Refers to a document serving as a section in a collection of documents. ( HL7V3.0 )] (UMLS (HL7) C1552858) =Idea or Concept =HtmlLinkType;
◊ [1 [mi_us]2 ( HL7V3.0 )] (UMLS (HL7) C1552924) Quantitative Concept UnitOfMeasureAtomInsens; UnitOfMeasureAtomSens |
- 831. second transplant
- [ ] (UMLS (CSP) C0599346) =Therapeutic or Preventive Procedure ;
| - 881. Section
- [A distinct region or subdivision of a territorial or political area or community. ( NCI )] (UMLS (NCI) C0205155) =Spatial Concept
|
- 832. Secondary
- [Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value. ( NCI )] (UMLS (NCI) C0175668) =Temporal Concept ;
| - 882. SECTOR OR ARCUATE DEFECT
- [ ] (UMLS (ICD9CM) C0155011) =Disease or Syndrome
|
- 833. Secondary Acute Granulocytic Leukemia
- [An acute myeloid leukemia secondary to a myelodysplastic syndrome or therapy-related. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C0280449) =Neoplastic Process
| - 883. secure hash algorithm - 1
- [This algorithm is defined in FIPS PUB 180-1: Secure Hash Standard. As of April 17, 1995. ( HL7V3.0 )] (UMLS (HL7) C1555416) =Intellectual Product =IntegrityCheckAlgorithm;
|
- 834. Secondary Amyloidosis
- (UMLS (NCI) C0221014) =Disease or Syndrome
| - 884. secure hash algorithm - 256
- [This algorithm is defined in FIPS PUB 180-2: Secure Hash Standard. ( HL7V3.0 )] (UMLS (HL7) C1555417) =Intellectual Product =IntegrityCheckAlgorithm;
|
- 835. Secondary and recurrent hemorrhage as an early complication of trauma
- [ ] (UMLS (ICD9CM) C0274267) =Injury or Poisoning
| - 885. Secured Medical Transport (VAN)
- [A public or privately owned transportation service with vehicles, specially equipped to provide enhanced safety, security and passenger restraint, and staffed by one or more individuals trained to work with patients in crisis situations resulting from mental or emotional illness and/or substance abuse. ( HL7V3.0 )] (UMLS (HL7) C1552512) =Intellectual Product ;
=Transportation Services;
|
- 836. secondary antibody deficiency
- [ ] (UMLS (CSP) C0597744) =Disease or Syndrome ;
| - 886. sedation
- [The process of allaying nervous excitement or the state of being calmed. (Taber's) ( NCI )] (UMLS (CSP) C0344106) =Therapeutic or Preventive Procedure ;
|
- 837. Secondary Carcinoma
- (UMLS (NCI) C0085668) =Neoplastic Process
| - 887. sedative
- [ ] (UMLS (CSP) C0036557) =Pharmacologic Substance
|
- 838. Secondary Chondrosarcoma
- [A low grade chondrosarcoma arising from a pre-existing benign chondrogenic neoplasm. It is characterized by the presence of myxoid changes and tissue invasion. When associated with Maffucci Syndrome, there is an increase in cellularity and nuclear atypia. Clinical presentation includes sudden pain or increased swelling. ( NCI )] (UMLS (NCI) C1335938) =Neoplastic Process
| - 888. Sedative, hypnotic or anxiolytic abuse
- (UMLS (ICD9CM) C0036550) =Mental or Behavioral Dysfunction
|
- 839. SECONDARY CORNEAL EDEMA
- [ ] (UMLS (ICD9CM) C0155110) =Disease or Syndrome ;
| - 889. Sedative, hypnotic or anxiolytic dependence
- (UMLS (ICD9CM) C0036552) =Mental or Behavioral Dysfunction
|
- 840. secondary degeneration
- [fatty degeneration of a nerve fiber which has been severed from its nutritive centers. ( CSP )] (UMLS (CSP) C0043020) =Cell or Molecular Dysfunction =Nerve Degeneration;
| - 890. Sedatives and hypnotics causing adverse effects in therapeutic use
- [ ] (UMLS (ICD9CM) C0261831) =Injury or Poisoning
|
- 841. Secondary hypertension
- [ ] (UMLS (ICD9CM) C0155616) =Disease or Syndrome
| - 891. Sediment
- (UMLS (HL7) C1550099) =Body Substance ;
=Specimen component;
|
- 842. secondary immune deficiency
- [ ] (UMLS (CSP) C0597745) =Disease or Syndrome ;
| - 892. sedimentation
- [settling of suspended particles within a liquid under the action of gravity or a centrifuge. ( CSP )] (UMLS (CSP) C1384604) =Natural Phenomenon or Process ;
=Physical Phenomenon;
|
- 843. secondary infection
- [infection by a microorganism following an infection by another kind of microorganism. ( CSP )] (UMLS (CSP) C0442886) =Disease or Syndrome =infection;
| - 893. Sedimentation
- [The act or process of settling particles by mechanical means from a state of suspension in air or water. ( NCI )] (UMLS (NCI) C0597428) =Laboratory Procedure
|
- 844. SECONDARY INSERT LENS
- [ ] (UMLS (ICD9CM) C0197750) =Therapeutic or Preventive Procedure
| - 894. sedimentation coefficient
- [ ] (UMLS (CSP) C0920727) =Quantitative Concept ;
|
- 845. Secondary iridocyclitis, infectious
- [ ] (UMLS (ICD9CM) C0154911) =Disease or Syndrome
| - 895. sedimentation constant
- [ ] (UMLS (CSP) C0920651) =Quantitative Concept ;
|
- 846. SECONDARY LACRIM ATROPHY
- [ ] (UMLS (ICD9CM) C0339121) =Acquired Abnormality; Disease or Syndrome
| - 896. sedimentation equilibrium
- [equilibrium between the forward movement of a sample's liquid sediment boundary and reverse diffusion during centrifugation; used in molecular weight determinations. ( CSP )] (UMLS (CSP) C0597429) =Natural Phenomenon or Process =Physical Phenomenon;
|
- 847. Secondary Lymphedema
- [A condition that is caused by trauma to the lymph system, which disrupts the normal flow of lymph fluid. This is most often due to surgery that requires lymph node removal or a large amount of lymph tissue. This disruption is especially apparent if the lymph nodes under the arm and arm and around the breast are compromised due to breast cancer surgery, diagnostic dissection, mastectomy, or radiation. ( NCI )] (UMLS (NCI) C0265191) =Disease or Syndrome ;
| - 897. sedimentation velocity
- [rate of movement of the liquid/sediment boundary in the sample holder during centrifugation; used in molecular weight determinations. ( CSP )] (UMLS (CSP) C0597430) =Quantitative Concept =Physical Phenomenon;
|
- 848. SECONDARY MALIG NEO NEC
- [ ] (UMLS (ICD9CM) C0153684) =Neoplastic Process
| - 898. see chapter 3
- (UMLS (HL7) C1549406) =Idea or Concept =race;
◊ (UMLS (HL7) C1549624) Population Group ethnic group; |
- 849. Secondary malignant neoplasm of respiratory and digestive systems
- (UMLS (ICD9CM) C0153675) =Neoplastic Process
| - 899. seed
- [structure containing 2 seed coats, endosperm tissue and embryo sporophyte, which serves to nourish and disperse plant sporophytes; usually formed inside flower. ( CSP )] (UMLS (CSP) C0036563) =Plant =plant morphology;
|
- 850. Secondary MDS
- (UMLS (NCI) C0280745) =Neoplastic Process
| - 900. SEER
- [A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From a brochure of the National Cancer Institute, NIH Publication No. 91-3074, October 1990) ( NCI )] (UMLS (NCI) C0242638) =Health Care Related Organization ;
|
home
